Location History:
- Milan MI, IT (1995)
- Milan, IT (1996 - 1999)
Company Filing History:
Years Active: 1995-1999
Title: Elena Folpini: Innovator in Cardiovascular Treatments
Introduction
Elena Folpini is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cardiovascular disorders. With a total of 5 patents to her name, Folpini's work is recognized for its innovative approach to addressing critical health issues.
Latest Patents
Among her latest patents, Folpini has developed 6-hydroxy and 6-oxo-androstane derivatives that are active on the cardiovascular system. These derivatives are characterized by a specific formula that includes various configurations and substituents, which enhance their therapeutic potential. Additionally, she has patented hydrazino and hydroxyamino-14-.beta.-hydroxyandrostane derivatives, which are designed for the treatment of cardiovascular disorders such as heart failure and hypertension. These inventions showcase her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Elena Folpini is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues to innovate in the pharmaceutical sector. Her work has not only contributed to her personal achievements but has also played a vital role in the company's mission to develop effective treatments for various health conditions.
Collaborations
Throughout her career, Folpini has collaborated with notable colleagues, including Piero Melloni and Alberto Cerri. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the field.
Conclusion
Elena Folpini stands out as a leading inventor in the pharmaceutical industry, particularly in the realm of cardiovascular treatments. Her patents reflect her dedication to improving health outcomes and her innovative spirit continues to inspire future advancements in medicine.